Ligand Partner GlaxoSmithKline Announces EU Regulatory Submission Seeking Additional Indication for RevoladeĀ® February 6, 2015
Ligand to Present at BIO CEO and RBC Capital Markets Global Healthcare Conferences in February January 28, 2015
Ligand Partner Melinta Therapeutics Reports Positive Phase 3 Results for Captisol-enabled⢠Delafloxacin IV January 8, 2015